CADD: predicting the deleteriousness of variants throughout the human genome.


Journal

Nucleic acids research
ISSN: 1362-4962
Titre abrégé: Nucleic Acids Res
Pays: England
ID NLM: 0411011

Informations de publication

Date de publication:
08 01 2019
Historique:
received: 14 09 2018
accepted: 11 10 2018
pubmed: 30 10 2018
medline: 16 5 2020
entrez: 30 10 2018
Statut: ppublish

Résumé

Combined Annotation-Dependent Depletion (CADD) is a widely used measure of variant deleteriousness that can effectively prioritize causal variants in genetic analyses, particularly highly penetrant contributors to severe Mendelian disorders. CADD is an integrative annotation built from more than 60 genomic features, and can score human single nucleotide variants and short insertion and deletions anywhere in the reference assembly. CADD uses a machine learning model trained on a binary distinction between simulated de novo variants and variants that have arisen and become fixed in human populations since the split between humans and chimpanzees; the former are free of selective pressure and may thus include both neutral and deleterious alleles, while the latter are overwhelmingly neutral (or, at most, weakly deleterious) by virtue of having survived millions of years of purifying selection. Here we review the latest updates to CADD, including the most recent version, 1.4, which supports the human genome build GRCh38. We also present updates to our website that include simplified variant lookup, extended documentation, an Application Program Interface and improved mechanisms for integrating CADD scores into other tools or applications. CADD scores, software and documentation are available at https://cadd.gs.washington.edu.

Identifiants

pubmed: 30371827
pii: 5146191
doi: 10.1093/nar/gky1016
pmc: PMC6323892
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

D886-D894

Subventions

Organisme : NCI NIH HHS
ID : R01 CA197139
Pays : United States
Organisme : NHGRI NIH HHS
ID : UM1 HG006493
Pays : United States
Organisme : NHGRI NIH HHS
ID : U54 HG006493
Pays : United States

Références

Hum Mutat. 2003 Jun;21(6):577-81
pubmed: 12754702
Nucleic Acids Res. 2003 Jul 1;31(13):3812-4
pubmed: 12824425
Genome Res. 2005 Aug;15(8):1034-50
pubmed: 16024819
Nature. 2009 Sep 10;461(7261):272-6
pubmed: 19684571
Genome Res. 2010 Jan;20(1):110-21
pubmed: 19858363
Nat Biotechnol. 2009 Dec;27(12):1173-5
pubmed: 19915551
Nat Methods. 2010 Apr;7(4):248-9
pubmed: 20354512
Nat Methods. 2010 Apr;7(4):250-1
pubmed: 20354513
Nucleic Acids Res. 2010 Sep;38(16):e164
pubmed: 20601685
PLoS Comput Biol. 2010 Dec 02;6(12):e1001025
pubmed: 21152010
Bioinformatics. 2011 Mar 1;27(5):718-9
pubmed: 21208982
Nat Rev Genet. 2011 Aug 18;12(9):628-40
pubmed: 21850043
Nat Biotechnol. 2012 Feb 26;30(3):265-70
pubmed: 22371081
Nucleic Acids Res. 2014 Jan;42(Database issue):D980-5
pubmed: 24234437
Nat Genet. 2014 Mar;46(3):310-5
pubmed: 24487276
Bioinformatics. 2015 Mar 1;31(5):761-3
pubmed: 25338716
PLoS Genet. 2014 Oct 30;10(10):e1004722
pubmed: 25357204
PLoS Genet. 2014 Nov 06;10(11):e1004697
pubmed: 25375159
Science. 2015 Jan 9;347(6218):1254806
pubmed: 25525159
Hum Mutat. 2015 Jul;36(7):712-9
pubmed: 25871441
Nat Genet. 2015 Aug;47(8):955-61
pubmed: 26075791
Nat Methods. 2015 Oct;12(10):931-4
pubmed: 26301843
Hum Mutat. 2016 Mar;37(3):235-41
pubmed: 26555599
Nat Genet. 2016 Feb;48(2):214-20
pubmed: 26727659
Nat Methods. 2016 Feb;13(2):109-10
pubmed: 26820543
Database (Oxford). 2016 May 02;2016:null
pubmed: 27141089
Genome Biol. 2016 Jun 06;17(1):122
pubmed: 27268795
Hum Mutat. 2016 Sep;37(9):865-76
pubmed: 27328919
Nature. 2016 Aug 17;536(7616):285-91
pubmed: 27535533
Am J Hum Genet. 2016 Sep 1;99(3):595-606
pubmed: 27569544
Am J Hum Genet. 2016 Oct 6;99(4):877-885
pubmed: 27666373
Nat Genet. 2016 Dec;48(12):1581-1586
pubmed: 27776117
Bioinformatics. 2017 Apr 1;33(7):1083-1085
pubmed: 28031184
Genome Biol. 2017 Jan 16;18(1):6
pubmed: 28093075
Nucleic Acids Res. 2017 Feb 17;45(3):e13
pubmed: 28180317
Cell. 2017 Feb 23;168(5):916-927.e12
pubmed: 28235201
Nat Genet. 2017 Apr;49(4):618-624
pubmed: 28288115
Database (Oxford). 2017 Jan 1;2017(1):
pubmed: 28365736
Eur J Hum Genet. 2017 Aug;25(8):973-981
pubmed: 28537274
Genome Med. 2017 May 30;9(1):43
pubmed: 28554332
BMC Evol Biol. 2017 Aug 4;17(1):179
pubmed: 28778150
Am J Hum Genet. 2017 Sep 7;101(3):315-325
pubmed: 28886340
Nature. 2017 Oct 19;550(7676):345-353
pubmed: 29019985
Genome Res. 2017 Dec;27(12):2015-2024
pubmed: 29097404
Nucleic Acids Res. 2018 Jan 4;46(D1):D762-D769
pubmed: 29106570
Genome Biol. 2017 Nov 28;18(1):225
pubmed: 29179779
Nat Commun. 2017 Nov 28;8(1):1826
pubmed: 29184056
Cell Syst. 2018 Jan 24;6(1):116-124.e3
pubmed: 29226803
Nat Genet. 2018 Mar;50(3):333-337
pubmed: 29483654
Mol Biol Evol. 2018 Aug 1;35(8):1916-1933
pubmed: 29796643
Nat Genet. 2018 Aug;50(8):1171-1179
pubmed: 30013180
Nat Genet. 2018 Aug;50(8):1161-1170
pubmed: 30038395
Nature. 2018 Oct;562(7726):217-222
pubmed: 30209399
BMC Bioinformatics. 2018 Oct 12;19(1):373
pubmed: 30314430
Bioinformatics. 2018 Dec 15;34(24):4307-4309
pubmed: 30535305
Science. 1974 Sep 6;185(4154):862-4
pubmed: 4843792
Genome Res. 1998 Mar;8(3):186-94
pubmed: 9521922

Auteurs

Philipp Rentzsch (P)

Berlin Institute of Health (BIH), 10178 Berlin, Germany.
Charité - Universitätsmedizin Berlin, 10117 Berlin, Germany.

Daniela Witten (D)

Department of Statistics and Biostatistics, University of Washington, Seattle, WA 98195, USA.

Gregory M Cooper (GM)

HudsonAlpha Institute for Biotechnology, Huntsville, AL 35806, USA.

Jay Shendure (J)

Department of Genome Sciences, University of Washington, Seattle, WA 98195, USA.
Brotman Baty Institute for Precision Medicine, Seattle, WA 98195, USA.

Martin Kircher (M)

Berlin Institute of Health (BIH), 10178 Berlin, Germany.
Charité - Universitätsmedizin Berlin, 10117 Berlin, Germany.
Department of Genome Sciences, University of Washington, Seattle, WA 98195, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH